ZA947783B - Method of treating depressed reticuloendothelial system function - Google Patents
Method of treating depressed reticuloendothelial system functionInfo
- Publication number
- ZA947783B ZA947783B ZA947783A ZA947783A ZA947783B ZA 947783 B ZA947783 B ZA 947783B ZA 947783 A ZA947783 A ZA 947783A ZA 947783 A ZA947783 A ZA 947783A ZA 947783 B ZA947783 B ZA 947783B
- Authority
- ZA
- South Africa
- Prior art keywords
- system function
- reticuloendothelial system
- depressed reticuloendothelial
- treating depressed
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13251093A | 1993-10-15 | 1993-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA947783B true ZA947783B (en) | 1996-05-05 |
Family
ID=22454373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA947783A ZA947783B (en) | 1993-10-15 | 1994-10-05 | Method of treating depressed reticuloendothelial system function |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0722333B1 (xx) |
AT (1) | ATE269099T1 (xx) |
AU (1) | AU7970894A (xx) |
CA (1) | CA2173611C (xx) |
DE (1) | DE69433848T2 (xx) |
HK (1) | HK1014498A1 (xx) |
WO (1) | WO1995010297A1 (xx) |
ZA (1) | ZA947783B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US5858974A (en) * | 1995-07-20 | 1999-01-12 | Xoma Corporation | Anti-fungal peptides |
US5643875A (en) * | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
US5447913A (en) * | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
PT914144E (pt) | 1996-05-10 | 2001-05-31 | Univ Texas | Utilizacoes terapeuticas de produtos de proteinas bip contra a meningococcemia humana |
US5741779A (en) | 1996-05-10 | 1998-04-21 | Xoma Corporation | Antithrombotic materials and methods |
DE69719754D1 (de) * | 1996-05-23 | 2003-04-17 | Xoma Technology Ltd | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
US6482796B2 (en) | 1996-11-01 | 2002-11-19 | Xoma Corporation | Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
US6013631A (en) * | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
EP1741440A1 (en) | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders |
GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
DK0690872T3 (da) * | 1993-03-12 | 1999-05-10 | Xoma Corp | Biologisk aktive peptider fra funktionelle domæner af baktericidt/permeabilitetsforøgende protein og anvendelser deraf |
-
1994
- 1994-10-05 CA CA002173611A patent/CA2173611C/en not_active Expired - Fee Related
- 1994-10-05 ZA ZA947783A patent/ZA947783B/xx unknown
- 1994-10-05 DE DE69433848T patent/DE69433848T2/de not_active Expired - Fee Related
- 1994-10-05 EP EP94930656A patent/EP0722333B1/en not_active Expired - Lifetime
- 1994-10-05 AT AT94930656T patent/ATE269099T1/de not_active IP Right Cessation
- 1994-10-05 AU AU79708/94A patent/AU7970894A/en not_active Abandoned
- 1994-10-05 WO PCT/US1994/011404 patent/WO1995010297A1/en active IP Right Grant
-
1998
- 1998-12-28 HK HK98115812A patent/HK1014498A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2173611A1 (en) | 1995-04-20 |
DE69433848D1 (de) | 2004-07-22 |
EP0722333B1 (en) | 2004-06-16 |
AU7970894A (en) | 1995-05-04 |
ATE269099T1 (de) | 2004-07-15 |
CA2173611C (en) | 2005-07-26 |
DE69433848T2 (de) | 2005-05-25 |
EP0722333A1 (en) | 1996-07-24 |
HK1014498A1 (en) | 1999-09-30 |
WO1995010297A1 (en) | 1995-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA947783B (en) | Method of treating depressed reticuloendothelial system function | |
HK1014158A1 (en) | Anti-fungal methods and materials | |
AU4959293A (en) | Microparticle preparations made from biodegradable copolymers | |
AU7327596A (en) | Preparation of phosphorothioate oligomers | |
GB9514451D0 (en) | Sustained-release formulation | |
PL336580A1 (en) | Fine-molecular compounds useful in treating inflammatory diseases | |
AU3909497A (en) | Anti-chlamydial methods and materials | |
GR3027620T3 (en) | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products | |
ZA955740B (en) | Anti-protozoan methods and materials | |
EP0722338A4 (en) | PROTEIN OR PEPTIDE COCHLEATE VACCINES AND IMMUNIZATION METHODS USING THE SAME | |
MX9602442A (es) | Un tratamiento con fluoroquinolona a dosis unica elevada. | |
MY115014A (en) | Mouth-care products | |
AU721852C (en) | Lipid metabolism improving agent | |
MY113431A (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
PL328948A1 (en) | Autism treating method | |
EP0663209A3 (en) | Medicines to inhibit the effects of amyloidogenic proteins. | |
IL126157A0 (en) | Method for treating excessive aggression | |
EP0651816A4 (en) | LEVELS OF CCK PEPTIDES IN BLOOD IN RELATION TO THE TREATMENT OF PANIC EARTHS. | |
IL126158A0 (en) | Method for treating substance abuse | |
DE69534740D1 (en) | Analoge des thymosin alpha 1 | |
PL335190A1 (en) | Application of 9,10-seccocholesta-5,7,10(19)-thiene1,3-diole i.e. alphazazidole | |
UA18224A (uk) | Спосіб лікуваhhя дерматозів | |
MX9803383A (es) | Preparacion de nitrilos de arilo y vinilo. | |
UA10259A (uk) | Протинабряковий лікарський препарат "нейрополіосм" | |
UA43389C2 (uk) | Спосіб зниження рівнів кальцію у сироватці |